COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes B Bigdelou, MR Sepand, S Najafikhoshnoo, JAT Negrete, M Sharaf, ... Frontiers in immunology 13, 890517, 2022 | 79 | 2022 |
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study MM Etter, TA Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ... Nature communications 13 (1), 6777, 2022 | 48 | 2022 |
Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery T Shekarian, CP Zinner, EM Bartoszek, W Duchemin, AT Wachnowicz, ... Science Advances 8 (26), eabn9440, 2022 | 26 | 2022 |
Brain cortical alterations in COVID-19 patients with neurological symptoms G Sanabria-Diaz, MM Etter, L Melie-Garcia, JM Lieb, MN Psychogios, ... Frontiers in neuroscience 16, 992165, 2022 | 17 | 2022 |
Initial experience with the trevo nxt stent retriever MM Etter, M Möhlenbruch, CS Weyland, C Pérez-García, M Moreu, ... Frontiers in neurology 12, 704329, 2021 | 4 | 2021 |
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: A prospective cross-sectional study MM Etter, T A. Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ... medRxiv, 2022.02. 18.22271039, 2022 | 3 | 2022 |
Endovascular Treatment and Peri-interventional Management of Ruptured Cerebrovascular Lesions During Pregnancy: Case Series and Case-based Systematic Review MM Etter, A Nguyen, A Brehm, C Aberle, I Tsogkas, R Guzman, ... Clinical Neuroradiology 33 (3), 833-842, 2023 | 2 | 2023 |
Brain cortical changes are related to inflammatory biomarkers in hospitalized SARS-CoV-2 patients with neurological symptoms G Sanabria-Diaz, MM Etter, L Melie-Garcia, J Lieb, MN Psychogios, ... medRxiv, 2022.02. 13.22270662, 2022 | 1 | 2022 |
IDENTIFICATION OF PLASMA-DERIVED PREDICTIVE BIOMARKERS INCLUDING SERPINA3 FOR GLIOMA AND GLIOBLASTOMA M Etter, W Duchemin, T Shekarian, C Durano, J Vogel, MF Ritz, G Hutter NEURO-ONCOLOGY 25, 2023 | | 2023 |
IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY N Tatari, HMS Hedad, A Zingg, EM Bartoszek, VJ Tschan, T Schenker, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
Endovascular Treatment and Peri-interventional Management of Ruptured Cerebrovascular Lesions During Pregnancy MM Etter, A Nguyen, A Brehm, C Aberle, I Tsogkas, R Guzman, ... | | 2023 |
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker TA Martins, N Tatari, D Kaymak, S Hogan, EM Bartoszek, R Wieboldt, ... bioRxiv, 2023.08. 31.555122, 2023 | | 2023 |
Treatment and Postinterventional Management of a Fusiform Intracranial Aneurysm in a Professional Soccer Player: A Case Report MM Etter, L Bonati, I Tsogkas, G Hutter, K Blackham, R Guzman, ... Frontiers in Neurology 12, 732640, 2022 | | 2022 |
EP52* Initial experience with the trevo NXT stent retriever MM Etter, M Möhlenbruch, CS Weyland, C Pérez-García, M Moreu, ... Journal of NeuroInterventional Surgery 13 (Suppl 2), A21-A22, 2021 | | 2021 |
Brain cortical changes are related to SARS-CoV-2 inflammatory biomarkers in hospitalized patients with neurological manifestations G Sanabria-Diaz, MM Etter, L Melie-Garcia, JM Lieb, MN Psychogios, ... | | |